Shuang Zhao

Dr. Shuang Zhao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2023 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JGJiamin Guo
Jiamin Guo
JHJunjie Hu
Junjie Hu
YZYichen Zheng
Yichen Zheng
SZShuang Zhao
Shuang Zhao
JMJi Ma
Ji Ma

28 June 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
JGJiamin Guo
Jiamin Guo
WMWenjun Meng
Wenjun Meng
QLQian Li
Qian Li
YZYichen Zheng
Yichen Zheng
HYHongKun Yin
HongKun Yin
JMJi Ma
Ji Ma
The association between sarcopenia and the effectiveness of neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) remains uncertain. This study aims to examine the potential of sarcopenia as a predictive factor for the response to NAC in TNBC, and to assess whether its combination with MRI radiomic signatures can improve the predictive accuracy. We collected clinical and pathological information, as well as pretreatment breast MRI and abdominal CT images, of 121 patients with TNBC who underwent NAC at our hospital between January 2012 and September 2021. The presence of pretreatment sarcopenia was assessed using the L3 skeletal muscle index. Clinical models were constructed based on independent risk factors identified by univariate regression analysis. Radiomics data were extracted on breast MRI images and the radiomics prediction models were constructed. We integrated independent risk factors and radiomic features to build the combined models. The results of this study demonstrated that sarcopenia is an independent predictive factor for NAC efficacy in TNBC. The combination of sarcopenia and MRI radiomic signatures can further improve predictive performance.

7 May 2021 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
ZHZixing Huang
Zixing Huang
SZShuang Zhao
Shuang Zhao
QLQi Leng
Qi Leng
SHShaoping Hu
Shaoping Hu
ZLZhenlin Li
Zhenlin Li
BSBin Song
Bin Song
During the coronavirus disease 2019 (COVID-19) pandemic period, container computed tomography (CT) scanners were developed and used for the first time in China to perform CT examinations for patients with clinically mild to moderate COVID-19 who did not need to be hospitalized for comprehensive treatment, but needed to be isolated in Fangcang shelter hospitals (also known as makeshift hospitals) to receive some supportive treatment. The container CT is a multidetector CT scanner installed within a radiation-protected stand-alone container (a detachable lead shielding room) that is deployed outside the makeshift hospital buildings. The container CT approach provided various medical institutions with the solution not only for rapid CT installation and high adaptability to site environments, but also for significantly minimizing the risk of cross-infection between radiological personnel and patients during CT examination in the pandemic. In this article, we described the typical setup of a container CT and how it worked for chest CT examinations in Wuhan city, the epicenter of COVID-19 outbreak.

8 September 2025 in European Journal of Radiology
Verified
Journal Article
Closed access
JGJiamin Guo
Jiamin Guo
YLYing Liu
Ying Liu
WRWei Ren
Wei Ren
YZYichen Zheng
Yichen Zheng
TRTonghui Ren
Tonghui Ren
SZShuang Zhao
Shuang Zhao

25 September 2025 in European Journal of Radiology
Verified
Journal Article
Closed access
JGJiamin Guo
Jiamin Guo
YLYing Liu
Ying Liu
WRWei Ren
Wei Ren
YZYichen Zheng
Yichen Zheng
TRTonghui Ren
Tonghui Ren
SZShuang Zhao
Shuang Zhao